▶ 調査レポート

世界のフェブキソスタットAPI市場インサイト・予測(~2027年)

• 英文タイトル:Global Febuxostat API Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界のフェブキソスタットAPI市場インサイト・予測(~2027年) / Global Febuxostat API Market Insights and Forecast to 2027 / QY2108PAL1161資料のイメージです。• レポートコード:QY2108PAL1161
• 出版社/出版日:QYResearch / 2021年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はフェブキソスタットAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。フェブキソスタットAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(純度≥98%、純度<98%)、用途別市場規模(フェブキソスタット錠、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・フェブキソスタットAPIの世界市場概要
・メーカー別の競争状況、市場シェア
・フェブキソスタットAPIの種類別市場規模:純度≥98%、純度<98%
・フェブキソスタットAPIの用途別市場規模:フェブキソスタット錠、その他
・北米のフェブキソスタットAPI市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのフェブキソスタットAPI市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのフェブキソスタットAPI市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のフェブキソスタットAPI市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのフェブキソスタットAPI市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Dr. Reddy’s Laboratories Ltd.、Gentec Pharmaceutical Group、Teva API、Chongqing Shenghuaxi Pharma. Co., Ltd、Zhejiang Ausun Pharmaceutical、Indoco Remedies Limited、Lupin Ltd、Waterstone Pharmaceuticals Inc.、ALP Pharm、Chongqing Fuan Pharmaceutical、Precise Group、Vasudha Pharma Chem、Hema Pharmaceuticals Pvt. Ltd
・フェブキソスタットAPIのバリューチェーン・販売チャネル分析
・フェブキソスタットAPIの世界市場動向

Febuxostat is an orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity. Upon oral administration, febuxostat selectively and noncompetitively inhibits the activity of xanthine oxidase, an enzyme that converts oxypurines, including hypoxanthine and xanthine, into uric acid. By inhibiting xanthine oxidase, uric acid production is reduced and serum uric acid levels are lowered. Febuxostat may provide protection against acute renal failure caused by the excessive release of uric acid that occurs upon massive tumor cell lysis resulting from the treatment of some malignancies.

Market Analysis and Insights: Global Febuxostat API Market
The global Febuxostat API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Febuxostat API Scope and Segment
Febuxostat API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Febuxostat API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Febuxostat Tablets Others By Company Dr. Reddy’s Laboratories Ltd. Gentec Pharmaceutical Group Teva API Chongqing Shenghuaxi Pharma. Co., Ltd Zhejiang Ausun Pharmaceutical Indoco Remedies Limited Lupin Ltd Waterstone Pharmaceuticals Inc. ALP Pharm Chongqing Fuan Pharmaceutical Precise Group Vasudha Pharma Chem Hema Pharmaceuticals Pvt. Ltd Production by Region India Europe China Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

1 Study Coverage
1.1 Febuxostat API Product Introduction
1.2 Market by Type
1.2.1 Global Febuxostat API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Febuxostat API Market Size Growth Rate by Application 1.3.2 Febuxostat Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Febuxostat API Production 2.1 Global Febuxostat API Production Capacity (2016-2027) 2.2 Global Febuxostat API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Febuxostat API Production by Region 2.3.1 Global Febuxostat API Historic Production by Region (2016-2021) 2.3.2 Global Febuxostat API Forecasted Production by Region (2022-2027) 2.4 India 2.5 Europe 2.6 China 3 Global Febuxostat API Sales in Volume & Value Estimates and Forecasts 3.1 Global Febuxostat API Sales Estimates and Forecasts 2016-2027 3.2 Global Febuxostat API Revenue Estimates and Forecasts 2016-2027 3.3 Global Febuxostat API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Febuxostat API Regions by Sales 3.4.1 Global Top Febuxostat API Regions by Sales (2016-2021) 3.4.2 Global Top Febuxostat API Regions by Sales (2022-2027) 3.5 Global Top Febuxostat API Regions by Revenue 3.5.1 Global Top Febuxostat API Regions by Revenue (2016-2021) 3.5.2 Global Top Febuxostat API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Febuxostat API Production Capacity by Manufacturers 4.2 Global Febuxostat API Sales by Manufacturers 4.2.1 Global Top Febuxostat API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Febuxostat API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Febuxostat API Sales in 2020 4.3 Global Febuxostat API Revenue by Manufacturers 4.3.1 Global Top Febuxostat API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Febuxostat API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Febuxostat API Revenue in 2020 4.4 Global Febuxostat API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Febuxostat API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Febuxostat API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Febuxostat API Sales by Type 5.1.1 Global Febuxostat API Historical Sales by Type (2016-2021) 5.1.2 Global Febuxostat API Forecasted Sales by Type (2022-2027) 5.1.3 Global Febuxostat API Sales Market Share by Type (2016-2027) 5.2 Global Febuxostat API Revenue by Type 5.2.1 Global Febuxostat API Historical Revenue by Type (2016-2021) 5.2.2 Global Febuxostat API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Febuxostat API Revenue Market Share by Type (2016-2027) 5.3 Global Febuxostat API Price by Type 5.3.1 Global Febuxostat API Price by Type (2016-2021) 5.3.2 Global Febuxostat API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Febuxostat API Sales by Application 6.1.1 Global Febuxostat API Historical Sales by Application (2016-2021) 6.1.2 Global Febuxostat API Forecasted Sales by Application (2022-2027) 6.1.3 Global Febuxostat API Sales Market Share by Application (2016-2027) 6.2 Global Febuxostat API Revenue by Application 6.2.1 Global Febuxostat API Historical Revenue by Application (2016-2021) 6.2.2 Global Febuxostat API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Febuxostat API Revenue Market Share by Application (2016-2027) 6.3 Global Febuxostat API Price by Application 6.3.1 Global Febuxostat API Price by Application (2016-2021) 6.3.2 Global Febuxostat API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Febuxostat API Market Size by Type 7.1.1 North America Febuxostat API Sales by Type (2016-2027) 7.1.2 North America Febuxostat API Revenue by Type (2016-2027) 7.2 North America Febuxostat API Market Size by Application 7.2.1 North America Febuxostat API Sales by Application (2016-2027) 7.2.2 North America Febuxostat API Revenue by Application (2016-2027) 7.3 North America Febuxostat API Sales by Country 7.3.1 North America Febuxostat API Sales by Country (2016-2027) 7.3.2 North America Febuxostat API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Febuxostat API Market Size by Type 8.1.1 Europe Febuxostat API Sales by Type (2016-2027) 8.1.2 Europe Febuxostat API Revenue by Type (2016-2027) 8.2 Europe Febuxostat API Market Size by Application 8.2.1 Europe Febuxostat API Sales by Application (2016-2027) 8.2.2 Europe Febuxostat API Revenue by Application (2016-2027) 8.3 Europe Febuxostat API Sales by Country 8.3.1 Europe Febuxostat API Sales by Country (2016-2027) 8.3.2 Europe Febuxostat API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Febuxostat API Market Size by Type 9.1.1 Asia Pacific Febuxostat API Sales by Type (2016-2027) 9.1.2 Asia Pacific Febuxostat API Revenue by Type (2016-2027) 9.2 Asia Pacific Febuxostat API Market Size by Application 9.2.1 Asia Pacific Febuxostat API Sales by Application (2016-2027) 9.2.2 Asia Pacific Febuxostat API Revenue by Application (2016-2027) 9.3 Asia Pacific Febuxostat API Sales by Region 9.3.1 Asia Pacific Febuxostat API Sales by Region (2016-2027) 9.3.2 Asia Pacific Febuxostat API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Febuxostat API Market Size by Type 10.1.1 Latin America Febuxostat API Sales by Type (2016-2027) 10.1.2 Latin America Febuxostat API Revenue by Type (2016-2027) 10.2 Latin America Febuxostat API Market Size by Application 10.2.1 Latin America Febuxostat API Sales by Application (2016-2027) 10.2.2 Latin America Febuxostat API Revenue by Application (2016-2027) 10.3 Latin America Febuxostat API Sales by Country 10.3.1 Latin America Febuxostat API Sales by Country (2016-2027) 10.3.2 Latin America Febuxostat API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Febuxostat API Market Size by Type 11.1.1 Middle East and Africa Febuxostat API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Febuxostat API Revenue by Type (2016-2027) 11.2 Middle East and Africa Febuxostat API Market Size by Application 11.2.1 Middle East and Africa Febuxostat API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Febuxostat API Revenue by Application (2016-2027) 11.3 Middle East and Africa Febuxostat API Sales by Country 11.3.1 Middle East and Africa Febuxostat API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Febuxostat API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Febuxostat API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Gentec Pharmaceutical Group 12.2.1 Gentec Pharmaceutical Group Corporation Information 12.2.2 Gentec Pharmaceutical Group Overview 12.2.3 Gentec Pharmaceutical Group Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Gentec Pharmaceutical Group Febuxostat API Product Description 12.2.5 Gentec Pharmaceutical Group Recent Developments 12.3 Teva API 12.3.1 Teva API Corporation Information 12.3.2 Teva API Overview 12.3.3 Teva API Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Teva API Febuxostat API Product Description 12.3.5 Teva API Recent Developments 12.4 Chongqing Shenghuaxi Pharma. Co., Ltd 12.4.1 Chongqing Shenghuaxi Pharma. Co., Ltd Corporation Information 12.4.2 Chongqing Shenghuaxi Pharma. Co., Ltd Overview 12.4.3 Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Product Description 12.4.5 Chongqing Shenghuaxi Pharma. Co., Ltd Recent Developments 12.5 Zhejiang Ausun Pharmaceutical 12.5.1 Zhejiang Ausun Pharmaceutical Corporation Information 12.5.2 Zhejiang Ausun Pharmaceutical Overview 12.5.3 Zhejiang Ausun Pharmaceutical Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Zhejiang Ausun Pharmaceutical Febuxostat API Product Description 12.5.5 Zhejiang Ausun Pharmaceutical Recent Developments 12.6 Indoco Remedies Limited 12.6.1 Indoco Remedies Limited Corporation Information 12.6.2 Indoco Remedies Limited Overview 12.6.3 Indoco Remedies Limited Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Indoco Remedies Limited Febuxostat API Product Description 12.6.5 Indoco Remedies Limited Recent Developments 12.7 Lupin Ltd 12.7.1 Lupin Ltd Corporation Information 12.7.2 Lupin Ltd Overview 12.7.3 Lupin Ltd Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Lupin Ltd Febuxostat API Product Description 12.7.5 Lupin Ltd Recent Developments 12.8 Waterstone Pharmaceuticals Inc. 12.8.1 Waterstone Pharmaceuticals Inc. Corporation Information 12.8.2 Waterstone Pharmaceuticals Inc. Overview 12.8.3 Waterstone Pharmaceuticals Inc. Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Waterstone Pharmaceuticals Inc. Febuxostat API Product Description 12.8.5 Waterstone Pharmaceuticals Inc. Recent Developments 12.9 ALP Pharm 12.9.1 ALP Pharm Corporation Information 12.9.2 ALP Pharm Overview 12.9.3 ALP Pharm Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 ALP Pharm Febuxostat API Product Description 12.9.5 ALP Pharm Recent Developments 12.10 Chongqing Fuan Pharmaceutical 12.10.1 Chongqing Fuan Pharmaceutical Corporation Information 12.10.2 Chongqing Fuan Pharmaceutical Overview 12.10.3 Chongqing Fuan Pharmaceutical Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Chongqing Fuan Pharmaceutical Febuxostat API Product Description 12.10.5 Chongqing Fuan Pharmaceutical Recent Developments 12.11 Precise Group 12.11.1 Precise Group Corporation Information 12.11.2 Precise Group Overview 12.11.3 Precise Group Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Precise Group Febuxostat API Product Description 12.11.5 Precise Group Recent Developments 12.12 Vasudha Pharma Chem 12.12.1 Vasudha Pharma Chem Corporation Information 12.12.2 Vasudha Pharma Chem Overview 12.12.3 Vasudha Pharma Chem Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.12.4 Vasudha Pharma Chem Febuxostat API Product Description 12.12.5 Vasudha Pharma Chem Recent Developments 12.13 Hema Pharmaceuticals Pvt. Ltd 12.13.1 Hema Pharmaceuticals Pvt. Ltd Corporation Information 12.13.2 Hema Pharmaceuticals Pvt. Ltd Overview 12.13.3 Hema Pharmaceuticals Pvt. Ltd Febuxostat API Sales, Price, Revenue and Gross Margin (2016-2021) 12.13.4 Hema Pharmaceuticals Pvt. Ltd Febuxostat API Product Description 12.13.5 Hema Pharmaceuticals Pvt. Ltd Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Febuxostat API Industry Chain Analysis 13.2 Febuxostat API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Febuxostat API Production Mode & Process 13.4 Febuxostat API Sales and Marketing 13.4.1 Febuxostat API Sales Channels 13.4.2 Febuxostat API Distributors 13.5 Febuxostat API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Febuxostat API Industry Trends 14.2 Febuxostat API Market Drivers 14.3 Febuxostat API Market Challenges 14.4 Febuxostat API Market Restraints 15 Key Finding in The Global Febuxostat API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Febuxostat API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Febuxostat API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Febuxostat API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Febuxostat API Production by Region (2016-2021) & (Ton)
Table 7. Global Febuxostat API Production Market Share by Region (2016-2021)
Table 8. Global Febuxostat API Production by Region (2022-2027) & (Ton)
Table 9. Global Febuxostat API Production Market Share by Region (2022-2027)
Table 10. Global Febuxostat API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Febuxostat API Sales by Region (2016-2021) & (Ton)
Table 12. Global Febuxostat API Sales Market Share by Region (2016-2021)
Table 13. Global Febuxostat API Sales by Region (2022-2027) & (Ton)
Table 14. Global Febuxostat API Sales Market Share by Region (2022-2027)
Table 15. Global Febuxostat API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Febuxostat API Revenue Market Share by Region (2016-2021)
Table 17. Global Febuxostat API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Febuxostat API Revenue Market Share by Region (2022-2027)
Table 19. Global Febuxostat API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Febuxostat API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Febuxostat API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Febuxostat API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Febuxostat API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Febuxostat API Sales Share by Manufacturers (2016-2021)
Table 25. Global Febuxostat API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Febuxostat API Revenue Share by Manufacturers (2016-2021)
Table 27. Febuxostat API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Febuxostat API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Febuxostat API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Febuxostat API as of 2020)
Table 30. Febuxostat API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Febuxostat API Product Offered
Table 32. Date of Manufacturers Enter into Febuxostat API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Febuxostat API Sales by Type (2016-2021) & (Ton)
Table 35. Global Febuxostat API Sales by Type (2022-2027) & (Ton)
Table 36. Global Febuxostat API Sales Share by Type (2016-2021)
Table 37. Global Febuxostat API Sales Share by Type (2022-2027)
Table 38. Global Febuxostat API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Febuxostat API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Febuxostat API Revenue Share by Type (2016-2021)
Table 41. Global Febuxostat API Revenue Share by Type (2022-2027)
Table 42. Febuxostat API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Febuxostat API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Febuxostat API Sales by Application (2016-2021) & (Ton)
Table 45. Global Febuxostat API Sales by Application (2022-2027) & (Ton)
Table 46. Global Febuxostat API Sales Share by Application (2016-2021)
Table 47. Global Febuxostat API Sales Share by Application (2022-2027)
Table 48. Global Febuxostat API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Febuxostat API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Febuxostat API Revenue Share by Application (2016-2021)
Table 51. Global Febuxostat API Revenue Share by Application (2022-2027)
Table 52. Febuxostat API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Febuxostat API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Febuxostat API Sales by Type (2016-2021) & (Ton)
Table 55. North America Febuxostat API Sales by Type (2022-2027) & (Ton)
Table 56. North America Febuxostat API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Febuxostat API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Febuxostat API Sales by Application (2016-2021) & (Ton)
Table 59. North America Febuxostat API Sales by Application (2022-2027) & (Ton)
Table 60. North America Febuxostat API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Febuxostat API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Febuxostat API Sales by Country (2016-2021) & (Ton)
Table 63. North America Febuxostat API Sales by Country (2022-2027) & (Ton)
Table 64. North America Febuxostat API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Febuxostat API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Febuxostat API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Febuxostat API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Febuxostat API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Febuxostat API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Febuxostat API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Febuxostat API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Febuxostat API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Febuxostat API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Febuxostat API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Febuxostat API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Febuxostat API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Febuxostat API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Febuxostat API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Febuxostat API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Febuxostat API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Febuxostat API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Febuxostat API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Febuxostat API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Febuxostat API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Febuxostat API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Febuxostat API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Febuxostat API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Febuxostat API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Febuxostat API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Febuxostat API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Febuxostat API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Febuxostat API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Febuxostat API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Febuxostat API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Febuxostat API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Febuxostat API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Febuxostat API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Febuxostat API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Febuxostat API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Febuxostat API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Febuxostat API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Febuxostat API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Febuxostat API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Febuxostat API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Febuxostat API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Febuxostat API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Febuxostat API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Febuxostat API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Febuxostat API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Febuxostat API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Febuxostat API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Febuxostat API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Febuxostat API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Febuxostat API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Gentec Pharmaceutical Group Corporation Information
Table 120. Gentec Pharmaceutical Group Description and Major Businesses
Table 121. Gentec Pharmaceutical Group Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Gentec Pharmaceutical Group Febuxostat API Product
Table 123. Gentec Pharmaceutical Group Recent Development
Table 124. Teva API Corporation Information
Table 125. Teva API Description and Major Businesses
Table 126. Teva API Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Teva API Febuxostat API Product
Table 128. Teva API Recent Development
Table 129. Chongqing Shenghuaxi Pharma. Co., Ltd Corporation Information
Table 130. Chongqing Shenghuaxi Pharma. Co., Ltd Description and Major Businesses
Table 131. Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Product
Table 133. Chongqing Shenghuaxi Pharma. Co., Ltd Recent Development
Table 134. Zhejiang Ausun Pharmaceutical Corporation Information
Table 135. Zhejiang Ausun Pharmaceutical Description and Major Businesses
Table 136. Zhejiang Ausun Pharmaceutical Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Zhejiang Ausun Pharmaceutical Febuxostat API Product
Table 138. Zhejiang Ausun Pharmaceutical Recent Development
Table 139. Indoco Remedies Limited Corporation Information
Table 140. Indoco Remedies Limited Description and Major Businesses
Table 141. Indoco Remedies Limited Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Indoco Remedies Limited Febuxostat API Product
Table 143. Indoco Remedies Limited Recent Development
Table 144. Lupin Ltd Corporation Information
Table 145. Lupin Ltd Description and Major Businesses
Table 146. Lupin Ltd Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Lupin Ltd Febuxostat API Product
Table 148. Lupin Ltd Recent Development
Table 149. Waterstone Pharmaceuticals Inc. Corporation Information
Table 150. Waterstone Pharmaceuticals Inc. Description and Major Businesses
Table 151. Waterstone Pharmaceuticals Inc. Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Waterstone Pharmaceuticals Inc. Febuxostat API Product
Table 153. Waterstone Pharmaceuticals Inc. Recent Development
Table 154. ALP Pharm Corporation Information
Table 155. ALP Pharm Description and Major Businesses
Table 156. ALP Pharm Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. ALP Pharm Febuxostat API Product
Table 158. ALP Pharm Recent Development
Table 159. Chongqing Fuan Pharmaceutical Corporation Information
Table 160. Chongqing Fuan Pharmaceutical Description and Major Businesses
Table 161. Chongqing Fuan Pharmaceutical Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Chongqing Fuan Pharmaceutical Febuxostat API Product
Table 163. Chongqing Fuan Pharmaceutical Recent Development
Table 164. Precise Group Corporation Information
Table 165. Precise Group Description and Major Businesses
Table 166. Precise Group Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Precise Group Febuxostat API Product
Table 168. Precise Group Recent Development
Table 169. Vasudha Pharma Chem Corporation Information
Table 170. Vasudha Pharma Chem Description and Major Businesses
Table 171. Vasudha Pharma Chem Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 172. Vasudha Pharma Chem Febuxostat API Product
Table 173. Vasudha Pharma Chem Recent Development
Table 174. Hema Pharmaceuticals Pvt. Ltd Corporation Information
Table 175. Hema Pharmaceuticals Pvt. Ltd Description and Major Businesses
Table 176. Hema Pharmaceuticals Pvt. Ltd Febuxostat API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 177. Hema Pharmaceuticals Pvt. Ltd Febuxostat API Product
Table 178. Hema Pharmaceuticals Pvt. Ltd Recent Development
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Febuxostat API Distributors List
Table 182. Febuxostat API Customers List
Table 183. Febuxostat API Market Trends
Table 184. Febuxostat API Market Drivers
Table 185. Febuxostat API Market Challenges
Table 186. Febuxostat API Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Febuxostat API Product Picture
Figure 2. Global Febuxostat API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Febuxostat API Market Share by Application in 2020 & 2027
Figure 6. Febuxostat Tablets
Figure 7. Others
Figure 8. Febuxostat API Report Years Considered
Figure 9. Global Febuxostat API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Febuxostat API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Febuxostat API Production Market Share by Region (2016-2021)
Figure 12. Global Febuxostat API Production Market Share by Region (2022-2027)
Figure 13. Febuxostat API Production Growth Rate in India (2016-2027) & (Ton)
Figure 14. Febuxostat API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Febuxostat API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Global Febuxostat API Sales 2016-2027 (Ton)
Figure 17. Global Febuxostat API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Febuxostat API Revenue 2016-2027 (US$ Million)
Figure 19. Global Febuxostat API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 20. Global Febuxostat API Sales Market Share by Region (2016-2021)
Figure 21. Global Febuxostat API Sales Market Share by Region (2022-2027)
Figure 22. North America Febuxostat API Sales YoY (2016-2027) & (Ton)
Figure 23. North America Febuxostat API Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Europe Febuxostat API Sales YoY (2016-2027) & (Ton)
Figure 25. Europe Febuxostat API Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Asia-Pacific Febuxostat API Sales YoY (2016-2027) & (Ton)
Figure 27. Asia-Pacific Febuxostat API Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Latin America Febuxostat API Sales YoY (2016-2027) & (Ton)
Figure 29. Latin America Febuxostat API Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Middle East & Africa Febuxostat API Sales YoY (2016-2027) & (Ton)
Figure 31. Middle East & Africa Febuxostat API Revenue YoY (2016-2027) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Febuxostat API Sales in 2020
Figure 33. The Top 10 and Top 5 Players Market Share by Febuxostat API Revenue in 2020
Figure 34. Febuxostat API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Global Febuxostat API Sales Market Share by Type (2016-2027)
Figure 36. Global Febuxostat API Revenue Market Share by Type (2016-2027)
Figure 37. Global Febuxostat API Sales Market Share by Application (2016-2027)
Figure 38. Global Febuxostat API Revenue Market Share by Application (2016-2027)
Figure 39. North America Febuxostat API Sales Market Share by Type (2016-2027)
Figure 40. North America Febuxostat API Revenue Market Share by Type (2016-2027)
Figure 41. North America Febuxostat API Sales Market Share by Application (2016-2027)
Figure 42. North America Febuxostat API Revenue Market Share by Application (2016-2027)
Figure 43. North America Febuxostat API Sales Share by Country (2016-2027)
Figure 44. North America Febuxostat API Revenue Share by Country (2016-2027)
Figure 45. United States Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 46. Canada Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 47. Europe Febuxostat API Sales Market Share by Type (2016-2027)
Figure 48. Europe Febuxostat API Revenue Market Share by Type (2016-2027)
Figure 49. Europe Febuxostat API Sales Market Share by Application (2016-2027)
Figure 50. Europe Febuxostat API Revenue Market Share by Application (2016-2027)
Figure 51. Europe Febuxostat API Sales Share by Country (2016-2027)
Figure 52. Europe Febuxostat API Revenue Share by Country (2016-2027)
Figure 53. Germany Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 54. France Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 55. U.K. Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 56. Italy Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 57. Russia Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 58. Asia Pacific Febuxostat API Sales Market Share by Type (2016-2027)
Figure 59. Asia Pacific Febuxostat API Revenue Market Share by Type (2016-2027)
Figure 60. Asia Pacific Febuxostat API Sales Market Share by Application (2016-2027)
Figure 61. Asia Pacific Febuxostat API Revenue Market Share by Application (2016-2027)
Figure 62. Asia Pacific Febuxostat API Sales Share by Region (2016-2027)
Figure 63. Asia Pacific Febuxostat API Revenue Share by Region (2016-2027)
Figure 64. China Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 65. Japan Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 66. South Korea Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 67. India Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 68. Australia Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 69. China Taiwan Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 70. Indonesia Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 71. Thailand Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 72. Malaysia Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 73. Latin America Febuxostat API Sales Market Share by Type (2016-2027)
Figure 74. Latin America Febuxostat API Revenue Market Share by Type (2016-2027)
Figure 75. Latin America Febuxostat API Sales Market Share by Application (2016-2027)
Figure 76. Latin America Febuxostat API Revenue Market Share by Application (2016-2027)
Figure 77. Latin America Febuxostat API Sales Share by Country (2016-2027)
Figure 78. Latin America Febuxostat API Revenue Share by Country (2016-2027)
Figure 79. Mexico Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 80. Brazil Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 81. Argentina Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 82. Middle East and Africa Febuxostat API Sales Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Febuxostat API Revenue Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Febuxostat API Sales Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Febuxostat API Revenue Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Febuxostat API Sales Share by Country (2016-2027)
Figure 87. Middle East and Africa Febuxostat API Revenue Share by Country (2016-2027)
Figure 88. Turkey Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 89. Saudi Arabia Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 90. UAE Febuxostat API Revenue (2016-2027) & (US$ Million)
Figure 91. Febuxostat API Value Chain
Figure 92. Febuxostat API Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed